Notice on Convening the 4th Extraordinary General Meeting in 2025
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Notice on Convening the 4th Extraordinary General Meeting in 2025
Filed with SSE · · 7 pages · Chinese
Release
Shandong Bailong Chuangyuan Bio-Tech Co. Ltd. on 6ix
Earlier from Shandong Bailong Chuangyuan Bio-Tech
- Announcement on Convening the Q3 2025 Performance and Cash Dividend Briefing
- Announcement on Preliminary Earnings Estimate for Q3 2025
- Announcement on Resolutions of the 3rd Extraordinary General Meeting in 2025
- Announcement on Extending the Validity Period of Resolution Period of Shareholders' General Meeting for Issuing Convertible Corporate Bonds to Non-specific Objects
- Announcement on Implementation of Semi-annual Dividend Distribution for 2025
Later from Shandong Bailong Chuangyuan Bio-Tech
- Announcement on Resolutions of the 4th Extraordinary General Meeting in 2025
- Announcement on Implementation of Dividend Distribution for Q3 2025
- Announcement on Resolutions of the 5th Extraordinary General Meeting in 2025
- Announcement on Preliminary Earnings Estimate for 2025
- Announcement on Outward Investing in Establishing a Wholly-owned Subsidiary in Nanjing
Follow Shandong Bailong Chuangyuan Bio-Tech into a list and get an email when it puts out news.
Follow Shandong Bailong Chuangyuan Bio-Tech